Department of Surgery, University of Alberta, Edmonton, AB, T6G 2B7, Canada.
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, T6G 2R7, Canada.
BMC Musculoskelet Disord. 2019 May 18;20(1):234. doi: 10.1186/s12891-019-2619-8.
A significant number of patients use opioids prior to total joint arthroplasty (TJA) in North America and there is growing concern that preoperative opioid use negatively impacts postoperative patient outcomes after surgery. This systematic review and meta-analysis evaluated the current evidence investigating the influence of preoperative opioid use on postoperative patient-reported outcomes (PRO) after total joint arthroplasty.
A systematic search was performed using Ovid, Embase, Cochrane Library, Scopus, Web of Science Core Collection, CINAHL on February 15th, 2018. Studies reporting baseline and postoperative PRO among those prescribed preoperative opioids and those who were not prior to total knee and hip arthroplasty were included. Standardized mean differences (SMD) in absolute difference and relative change in PRO measures between the two groups was calculated using random effect models.
Six studies were included (n = 7356 patients); overall 24% of patients were prescribed preoperative opioids. Patients with preoperative opioid use had worse absolute postoperative PRO scores when compared to those with no preoperative opioid use (standardized mean difference (SMD) -0.53, 95% Confidence interval (CI) -0.75, - 0.32, p < 0.0001). When relative change in PRO score was analyzed, as measured by difference between postoperative and preoperative PRO scores, there was no group differences (SMD -0.26, 95% CI -0.56, 0.05, p = 0.10).
Patients prescribed preoperative opioids may attain worse overall pain and function benefits after TJA when compared to opioid-naïve patients, but do still benefit from undergoing TJA. These results suggest preoperative opioid users should be judiciously counselled regarding potential postoperative pain and function improvements after TJA.
在北美,相当数量的患者在接受全关节置换术(TJA)之前使用阿片类药物,人们越来越担心术前使用阿片类药物会对手术后患者的术后结果产生负面影响。本系统评价和荟萃分析评估了目前关于术前使用阿片类药物对全关节置换术后患者报告的术后结果(PRO)的影响的证据。
2018 年 2 月 15 日,使用 Ovid、Embase、Cochrane 图书馆、Scopus、Web of Science 核心合集、CINAHL 进行了系统搜索。报告术前开具阿片类药物和未开具阿片类药物的全膝关节和全髋关节置换术患者的基线和术后 PRO 的研究被纳入。使用随机效应模型计算两组之间 PRO 测量值的绝对差异和相对变化的标准化均数差异(SMD)。
纳入了 6 项研究(n=7356 例患者);总体而言,24%的患者开具了术前阿片类药物。与未开具术前阿片类药物的患者相比,使用术前阿片类药物的患者术后 PRO 评分更差(标准化均数差异(SMD)-0.53,95%置信区间(CI)-0.75,-0.32,p<0.0001)。当分析以术后和术前 PRO 评分之间的差异表示的 PRO 评分的相对变化时,两组之间没有差异(SMD-0.26,95%CI-0.56,0.05,p=0.10)。
与阿片类药物未使用者相比,术前开具阿片类药物的患者在接受 TJA 后可能获得更好的整体疼痛和功能益处,但仍受益于 TJA。这些结果表明,术前阿片类药物使用者应谨慎告知他们 TJA 后潜在的术后疼痛和功能改善。